UPM-Kymmene Oyj (UPM)
Helsinki Exchange · Finland · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 24.40 |
|---|---|
| 52-week range | 22.12 – 27.94 |
| Return, 1 month / 3 months | −6.2% / +1.2% |
| Return, 1 year / 3 years | +14.7% / −6.4% |
| Trend | Below its 200-day average |
| RSI (14) | 43 |
| Volatility (1 year) | 23.6% |
| Worst drawdown (1 year) | -17.9% |
| Average daily value traded | 25.95M EUR |
| Dividend yield | 6.1% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
UPM-Kymmene Oyj is a Finnish forest products company based in Helsinki. It makes pulp, paper and paperboard for packaging and printing, and produces plywood, timber and other wood products for construction and industrial customers. Its businesses also include self-adhesive label materials, specialty papers, and renewable energy and biochemicals. Customers are mainly manufacturers, converters, printers, packagers and builders across international markets, and the company manages forests and pulp mills that supply its own production.
UPM-Kymmene Oyj trades under the code UPM on the Helsinki Exchange in Finland, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
UPM-Kymmene Oyj (UPM) trades on the Helsinki Exchange in Finland. It last closed at EUR 24.40 on 22 October 2026.
Its price-based Market X-Ray is 72 out of 100 (a strong price profile), ranking 34 of 190 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 14.7% and over the last three months it rose 1.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Helsinki Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 63 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.4% | ||
| From 52-week high | -12.1% | ||
| Momentum | 60 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 1.2% | ||
| 6-month return | -7.4% | ||
| 12-month return, skipping the last month | 22.3% | ||
| Stability (higher is calmer) | 78 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -17.9% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 25.95M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 6.1% | ||
| Years with dividends | 5 |
Strengths
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
- Liquidity: Trades actively.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −2.3% |
|---|---|
| 1 month | −6.2% |
| 3 months | +1.2% |
| 6 months | −7.4% |
| 1 year | +14.7% |
| 3 years | −6.4% |
| 5 years | −0.7% |
Signals
| 50-day / 200-day average | 24.66 / 24.75 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.47 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 29 Oct 2026 | EUR 0.7500 |
| 10 Apr 2026 | EUR 0.7500 |
| 30 Oct 2025 | EUR 0.7500 |
| 28 Mar 2025 | EUR 0.7500 |
| 30 Oct 2024 | EUR 0.7500 |
| 5 Apr 2024 | EUR 0.7500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Helsinki Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.